• Japanese
  • Korean
  • Chinese
Cover Image

Needle-Free Drug Injection Systems and Safety Syringes

Abstract

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as First Principals, Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, Bioject Medical Technologies, Inc., Covidien Plc, Crossject Ltd., D'Antonio Consultants International, Inc., Glide Pharmaceutical Technologies Ltd., Incline Therapeutics, Inc., INJEX Pharma GmbH, Medical International Technologies (Mit Canada), Inc., National Medical Products, Inc., PenJet Corporation, PowderJect Pharmaceuticals Plc, Retractable Technologies, Inc., Safety Syringes, Inc., Smiths Group, Smiths Medical, Terumo Corporation, Unilife Medical Solutions Ltd., Valeritas, Ypsomed Holding AG, and Zogenix, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Safety Syringes
    • Needle-Free Injections

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Market Overview
  • Current and Future Analysis
  • Needlestick Injuries - A Menace in Healthcare Environment
  • Evolving Drug Delivery Systems
  • Factors Determining User Choice in Safety Syringes
  • Factors Enabling Espousal of Safety and Pre-filled Injections
  • Major Advantages of Needle-Free Injection Systems
  • Legislations - The Base for Technology Improvements and Demand
  • Ongoing Research to Further Advance Delivery Systems, Fuel Market Growth
  • Future Market to Offer Multiple Drug Delivery Alternatives
  • Needle-Free Injection Systems Market
  • Demand for Needle-Free Systems Gathers Pace
  • Trends toward Needle-Free Injections
  • Extending Patent Life through Differentiation from Competitive Generics
  • Safety and Efficacy - Amongst the Prime Motivating Factors
  • Patient Involvement
  • Needle-Free Future Unlikely
  • Regulations - A Shot on the Arm for Needle-free Market
  • Safety Syringes Market
  • Demand for Pre-filled Safety Syringes North-Bound
  • Pre-filled Syringes - Benefiting All Stakeholders
  • Markets Crave for Further Advancements in Safety Syringes
  • Insulin Delivery - A Burgeoning Market for Novel Delivery Systems
  • Competitive Landscape
    • Table 1: Leading Suppliers of Safety Syringes Worldwide (2011E): Percentage Breakdown of Sales for Becton, Dickinson and Company, Covidien, Terumo, Retractable and Others (includes corresponding Graph/Chart)
  • Other Key Statistics
    • Table 2: Leading Pharmaceutical Companies in the Pre-Filled Vaccine Syringes Market (2011): Percentage Breakdown of Revenues for GSK, Sanofi, Novartis and Others (includes corresponding Graph/Chart)
    • Table 3: Leading Pharmaceutical Companies in the Pre-Filled Hematology Syringes Market (2011): Percentage Breakdown of Revenues for Roche, Amgen and Others (includes corresponding Graph/Chart)
    • Table 4: Leading Pharmaceutical Companies in the Pre-Filled Anti-Coagulant Syringes Market (2011): Percentage Breakdown of Revenues for Sanofi, GSK and Others (includes corresponding Graph/Chart)
  • Ready-to-Fill Segment Goes Strong
    • Table 5: Global Ready-to-Fill Syringe Consumption: 2007-2011 (In Billion Units) (includes corresponding Graph/Chart)
    • Table 6: Leading Pharmaceutical Companies by Pre-filled Syringe Consumption (2011): Percentage Breakdown of Value Consumption for Sanofi, GSK, Novartis, Pfizer, Roche and Others (includes corresponding Graph/Chart)
    • Table 7: World Sales of Drugs in Pre-filled Syringes by Therapeutic Class (2011): Percentage Breakdown of Revenues for Vaccines, Hematology, Multiple Sclerosis, Anti-inflammatory, Anticoagulants and Others (includes corresponding Graph/Chart)

2. PRODUCT OVERVIEW

  • Introduction
  • Historical Background
  • Mechanism
  • Safety Syringe
  • Pre-Filled Syringe
  • Oral Vaccines
  • Nasal Sprays, Suppositories and Eye and Nose Drops
  • Inhalers
  • Transdermal
    • Injected Fine Mist or Powder
    • Jet Injectors
    • Iontophoretic Transdermal
    • Patches
    • Implants
    • Microneedles
  • Material Used for Production
  • Designing of Needle-free Injection Systems
  • The Production Process
  • Manufacturing the Pieces
  • Assembling and Labeling
  • Packaging
  • Quality Control
  • Safe Medical Devices
  • Auto-Injectors and Pen Injector
  • Benefits for Human
  • Greater Patient Acceptance and Compliance
  • Enhanced Safety
  • Improved Effectiveness
  • Swift Injection Time
  • Advantages of Using Needle-Free Injectors in Animals
  • Disease Transmission Reduction
  • Immunology Improvement
  • Improvement in Beef Quality
  • Employee Safety
  • Needle-free Delivery of Liquids and Solids

3. PRODUCT INTRODUCTIONS

  • Revolutions Medical Launches New Improved Website
  • MedPro Safety Products Launches Pre-filled Safety Syringe
  • MedPro Safety Products Launches Passive Hypodermic Safety Syringe
  • Greiner Bio-One and MedPro Safety Products Launch PREMIUM Safety Needle System Tube-Touch
  • MIT Introduces MED-JET® Products in the Russian Market
  • Revolutions Medical Develops Pre-filled Auto Retractable Vacuum Safety Syringes
  • ALK-Abello Unveils Jext - A New Adrenaline Auto-Injector
  • Fred Meyer Stores Offers Bioject Medical Technologies' Biojector® 2000
  • Revolutions Medical Introduces New Automatic Retractable Safety Syringe Designs
  • Revolutions Medical Unveils 3ml RevVac Safety Syringe
  • SCHOTT Pharmaceutical Packaging Develops InJentle™
  • PharmaJet Develops Needle-Free Jet Injection Technology
  • Smiths Medical Launches Medfusion® 4000 Syringe Infusion Pump
  • Teva Pharmaceutical Industries Rolls Out New Tjet™ Needle-Free Injector System
  • Occupational and Medical Innovations Rolls Out Auto-Retractable Safety Syringe
  • Pharmastandard to Launch Ypsomed's Ypsopen in Russia

4. RECENT INDUSTRY ACTIVITY

  • Insvet and AcuShot™ Ink Distribution Agreement
  • Antares Pharma Receives US Patent for Vibex™ Technology
  • Paketeria Acquires INJEX Pharma
  • Unilife Commences Sale of Unifill Ready-to-fill Syringes to Multinational Pharmaceutical Company
  • Zogenix and DURECT Sign Development and License Agreement
  • Clinigen Pharma and Zogenix Sign Collaborative Agreement
  • Bioject Medical Technologies to Supply Intradermal Pen
  • Revolutions Medical to Manufacture 5 million RevVac 1ml Fixed Needle Safety Syringe Every Month
  • Revolutions Medical Receives Clearance from the DLA for the RevVac Safety Syringe
  • Revolutions Medical Files Provisional Patent Application for Vacuum Technology-based Pre-Filled Safety Syringes
  • Medical International Technology Gains Chinese SFDA Certification for MED-JET® Products
  • Revolutions Medical and CeifiT Ink Marketing and Distribution Agreement
  • Revolutions Medical and DS WorldMed Ink Marketing and Distribution Agreement
  • Revolutions Medical and Wuxi Yushou Medical Appliance Ink Definitive Manufacturing Agreement
  • INJEX Pharma and Al Shamali Group Ink an Exclusive Distributor Contract
  • INJEX Pharma Inks Exclusive Sales and Marketing Agreement with GenTech Laboratories for INJEX Needle-Free Syringes
  • Unilife Bags Supply Contract for Unitract Safety Syringes from Premier Purchasing Partners
  • US FDA Grants Two 510(k) Marketing Clearances for PharmaJet's IM/SC Injection Technology
  • Zogenix Ends Co-Promotion Agreement with Astellas Pharma for the SUMAVEL DosePro
  • Kroger Include PharmaJet Needle-Free Injection Systems in Flu-Shot Campaign
  • Valeritas' V-Go™ Disposable Insulin Delivery Medical Device Obtains CE Mark Approval
  • Revolutions Medical Receives Patent for Marketing RevVac Safety Syringe in the Chinese Market
  • Zogenix and Desitin Obtain Marketing Approval for SUMAVEL DosePro
  • Smiths Medical to Establish Subsidiary in India
  • Unilife Commences Unifill Pre-filled Syringe Production
  • PharmaJet Secures FDA Clearance for Intradermal Needle-Free Injection Device
  • Cadence Enters into Agreement for Acquiring Incline Therapeutics
  • PharmaJet Signs Collaboration Agreement with USAMRIID
  • Revolution Medical and Santa Monica Pharmaceutica Enter into Strategic Partnership
  • Standard Chem and Pharm Enters into Distribution Agreement with Unilife
  • Bioject Medical Technologies and MPI Research Enter into Alliance
  • Revolutions Medical and MIG Sign Manufacturing Agreement
  • Protectus Medical Devices Inks Agreement with Moll
  • Unilife Starts Selling Unitract® 1ml Syringes
  • Inviragen and PharmaJet Obtain NIAID Contract for Developing Needle-Free Dengue Vaccine
  • Safety Syringes Selects Polycarbonate Resin of Bayer MaterialScience
  • Incline Therapeutics and ALZA Enter into Agreement
  • Desitin Pharmaceuticals and Zogenix Obtain Marketing Authorization for SUMAVEL® DosePro™ from Danish Medicines Agency
  • Antares Pharma Announces Advancements in Vibex™ Auto-Injectors
  • TOLMAR Holding Acquires QLT USA
  • SquareOne Medical Completes Reverse Merger into E-18
  • West Pharmaceutical Services Takes Over Assets of Plastef Investissements
  • Revolutions Medical Obtains FDA Approval for Marketing Rev Vac Safety Syringe
  • Bioject Medical Technologies and Ferring Pharmaceuticals Extend Supply Agreement
  • Med-Pharmex and AcuShotTM Ink Exclusive Distribution Agreement
  • Revolutions Medical and Libra International Ink Distribution Agreement
  • Cardinal Health and OMI Ink Exclusive Distribution Agreement
  • Astellas Pharma and Zogenix Ink Agreement to Co-Promote Sumavel DosePro
  • Unilife and Sanofi Winthrop Industrie Ink Industrialization Agreement
  • Bioject Medical Technologies Receives FDA 510(k) Clearance for ZetajetTM
  • PharmaJet Collaborates with PATH
  • Lipoxen and Glide Pharma Ink Agreement
  • Ypsomed Holding and Gamma Medica Enter into Distribution Agreement
  • Zogenix Receives FDA Approval for SUMAVEL® DoseProTM

5. FOCUS ON SELECT KEY PLAYERS

  • First Principals, Inc. (US)
  • Cambridge Consultants Ltd. (UK)
  • Antares Pharma, Inc. (US)
  • Bard Biopsy Systems (US)
  • Baxter International, Inc. (US)
  • Baxter BioPharma Solutions (US)
  • Bector, Dickinson (US)
  • BD Medical
  • Bioject Medical Technologies, Inc. (US)
  • Covidien Plc (Ireland)
  • Crossject Ltd. (France)
  • D'Antonio Consultants International, Inc. (US)
  • Glide Pharmaceutical Technologies Ltd. (UK)
  • Incline Therapeutics, Inc. (US)
  • INJEX Pharma GmbH (Germany)
  • Medical International Technologies (Mit Canada), Inc. (Canada)
  • National Medical Products, Inc. (US)
  • PenJet Corporation
  • PowderJect Pharmaceuticals Plc (UK)
  • Retractable Technologies, Inc. (US)
  • Safety Syringes, Inc. (US)
  • Smiths Group (UK)
  • Smiths Medical (US)
  • Terumo Corporation (Japan)
  • Unilife Medical Solutions Ltd. (US)
  • Valeritas (US)
  • Ypsomed Holding AG (Germany)
  • Zogenix, Inc. (US)

6. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 10: World 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • The Torch Bearers
    • Leading Players Operating in the Largest Individual Market
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: US Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 12: US Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Medical International Technologies (Mit Canada), Inc. - A Leading Canadian Player
  • B. Market Analytics
    • Table 13: Canadian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 14: Canadian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Terumo Corporation - A Leading Japanese Player
  • B. Market Analytics
    • Table 15: Japanese Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 16: Japanese Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Region-Wide Laws on Safety Syringes on the Cards
  • B. Market Analytics
    • Table 17: European Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 18: European Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 19: European 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
    • Crossject Ltd. - A French Player
  • B. Market Analytics
    • Table 20: French Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 21: French Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 22: German Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: German Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 24: Italian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 25: Italian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 26: UK Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 27: UK Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 28: Spanish Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 29: Spanish Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launches
  • B. Market Analytics
    • Table 30: Russian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 31: Russian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Covidien Plc - An Irish Player
  • B. Market Analytics
    • Table 32: Rest of Europe Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 33: Rest of Europe Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Demand for Safety Syringes in Asia Yet to Take Off
    • Safety Syringe Market in India Sets Off
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 34: Asia-Pacific Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 35: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 36: Rest of World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 37: Rest of World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing
Get Notified
Email me when related reports are published